Investment
Features
FeesSafety
Academy
More
Pluang+

Argo Gold reports July 2026 oil production of 2,203 barrels with $182K revenue and $109K net cash flow.

Market News
18 Sep 2026
Newsfile Corp
View Source
Bullish
Argo Gold reports July 2026 oil production of 2,203 barrels with $182K revenue and $109K net cash flow.

In July 2026, Argo Gold produced 2,203 barrels of oil, averaging 71 barrels per day. With oil prices averaging CAD$83 per barrel, the company generated $182,443 in revenue and $109,516 in net operating cash flow. Production contributions came from several interests including Lindbergh and Lloyd sites. This steady output and cash flow highlight Argo Gold's ongoing operations in oil production alongside its mineral exploration activities.

Argo Gold's June oil production reached 2,203 barrels, generating $182,443 in revenue. For readers following energy stocks, here is Pluang's market snapshot as of Sep 18, 2026 20:21 WIB: out of 34 priced US energy stocks, 12 rose and 22 fell. Notable movers include Shell PLC (SHEL) at USD 94.56 with a 1-day change of -1.31%, Ecopetrol SA (EC) at USD 17.21 down 0.98%, and Cenovus Energy Inc (CVE) at USD 33.18 up 0.82%.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
50 minutes ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App